Company
United StatesPublic company, NASDAQ: CORTCorcept Therapeutics Incorporated (NASDAQ: CORT), Menlo Park, CA – FDA Inspections
Inspection records and compliance data for Corcept Therapeutics Incorporated in Menlo Park, California. 4 FDA inspections on record, last inspected October 24, 2025. Publicly traded as NASDAQ: CORT.
Company Profile
This profile covers Corcept Therapeutics Incorporated based in Menlo Park, California, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected May 9, 2014. Last inspected October 24, 2025.
Most cited issue areas
- Failure to develop written procedures1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 24, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1291250 |
| May 19, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1271321 |
| October 19, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1135596 |
| May 9, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 879842 |
FDA documents
Form 483s (1)
EIRs (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Corcept Therapeutics Incorporated
Stock ticker
CORT
Exchange
NASDAQ
Share price
$73.71
Market cap
$8.1B
Price as of
November 13, 2026
FEI Number
3005389393
Address
149 Commonwealth Dr, Menlo Park, California 94025, United States
Country
United States
ID: 9f3284cd-b285-4408-818e-19b78043d2e3